If we don't allow enough data exclusivity time, we're not going to develop these therapies, especially in bio, because bio is one of four or five places, four or five techniques, where we can actually find treatments and cures.
Hatch emphasizes the importance of data exclusivity for developing therapies.
Share
More from Orrin Hatch
Those backlogs at the Social Security Administration are unacceptable to many, if not most, of us here in the Senate.
Having a confirmed Commissioner and sustained leadership will benefit the Social Security Administration.
Understanding what is happening in field and regional offices is critical in the role of executive leader of the agency.
Other voices in this conversation
